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Renal metastasis from non-small cell lung cancer is rather uncommon. The mechanism underlying the occurrence
of metastasis in this site is still not well understood. We report a case of a 53-year-old Chinese woman who had
moderately differentiated squamous cell carcinoma of the lung. After a ten months post-surgery interval of disease
free survival, computed tomography (CT) scan found that left renal parenchymal was occupied by a mass,
confirmed by kidney biopsy to be a metastasis from squamous cell lung carcinoma. Based on this case, we are
warned to be cautious in diagnosis and treatment when renal lesion are detected.
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The morbidity and mortality of lung cancer tend to
increase at present, and its mortality rate is the highest
among all types of cancer in China [1]. Although a great
progress has been made in the treatments of this tumor,
especially in non-small cell lung cancer (NSCLC), the
5 years survival rate of NSCLC is still lower than 15%
[2]. More than 1/3 of NSCLC patients are diagnosed with
distant metastasis, which is mainly due to difficulties in
early detection. Local symptoms caused by primary tumors
and complications due to distant metastases of NSCLC
are major factors endangering patients’ lives. The most
common site of metastasis via the hematogenous route is
brain, followed by bone, liver, adrenal gland, and lung.
However, metastasis of renal parenchymal is rather un-
common. Here we describe a case of lung carcinoma
causing isolated unilateral renal metastases.Case presentation
A 53-year-old Chinese woman presented symptoms of
cough, bloody sputum at the first visit. One month later,
enhanced chest CT scan showed a peripheral mass 5 cm
in the greatest size in the left upper lung, without obvious
enlargement of hilar and mediastinal lymph nodes. Subse-
quent whole body CT scan showed no distant metastasis
in brain, liver and kidney. Then she had left upper* Correspondence: yangjiyuanchina@163.com
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reproduction in any medium, provided the orlobectomy and chest lymph nodes exploration. Post-
operation pathologic examination revealed moderately dif-
ferentiated squamous cell carcinoma, with one metastatic
lymph node in the fifth station, and two metastatic lymph
nodes in the lung hilum (pT2N2M0). The immunohisto-
chemical staining was positive for PCK, CK5/6, 34βE12,
P63, CK17, and negative for CK19, TTF-1, CK7, CK20,
Ki67 > 10%. After surgery, the patient was given four cycles
of postoperative adjuvant chemotherapy with cisplatin and
vinblastine. Because of incomplete dissection of medias-
tinal lymph nodes and pathologic N2 disease, the patient
was subsequently treated with mediastinal radiotherapy, 50
Gy in all at 2 Gy per day, five days per week for five weeks.
After 10 months of disease free interval, a routine urine test
showed WBC 20 and RBC 5–10 per high-power field;
enhanced CT scan showed an occupying lesion in the left
renal parenchyma and paraaortic lymph node enlargement
(Figure 1), while brain MRI and liver CT scan showed no
other distant metastasis. In addition, B ultrasound guided
left kidney biopsy was performed and immunohistochem-
ical staining of the biopsy specimen showed: metastatic
squamous cell lung carcinoma, with the same positive
tumor biomarkers as in the surgical lung sample (Figure 2).Discussion
Tumor metastasis is a process that includes shedding,
adhesion, penetration, migration and proliferation of
primary tumor cells. A variety of cytokines, proteins,
and genes are involved in the process. The tumor cells. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 NSCLC renal metastasis. Computed tomography scan (A) and enhanced scan (B).
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domly, but tend to seed in selected organs. Mechanisms
underlying this targeted metastases are still unclear. The
“seed soil” hypothesis proposed by Fidler [3] considers
that the tumor cells transfer to any location equally, but
they can only grow in specific sites able to provide suitable
environment for the growth (soil). The tumor cells enter-
ing the cycle have receptors specifically binding to the
endothelial cells of target organs through special chemo-
tactic factors produced by them (seed); thus the tumor
cells are preferentially attracted to the target organ (seed
soil). In addition, the anatomical structure of the primary
lesion, the inherent anatomic structure of the target organ
and other factors can have effect on tumor production of
metastates to target organs.
Renal metastases frequently do not present clinical
symptoms and many patients have no hematuria orFigure 2 NSCLC renal metastasis. Renal biopsy specimen : Hematoxylin-e
CK5/6 (C) and TTF-1(D).hyperazotemia. According to literature, renal metastatic
tumors mainly locate in the cortical zone close to glom-
erular vascular plexus and seldom spread to urothelial
tissue, so that the incidence of microscopic hematuria is
12% ~ 31% [4]. Single renal tumors include renal cell
carcinoma and renal angiomyolipoma. Multiple renal
tumors include multiple renal infarctions and multiple
renal cysts. Identification of tumors metastatic to kidney,
so as of renal cell carcinoma, renal angiomyolipoma and
renal cysts, relies on kidney biopsy. In this report, the
immunohistochemical staining of left kidney biopsy speci-
men showed positive CK5/6,34βE12, and P63 markers,
whereas the TTF-1 was negative. These results indicated
that the renal mass derived from the primary lung squa-
mous cell carcinoma [5], and it was not a renal cell carcin-
oma. Renal metastases from NSCLC are restricted to a
few anecdotal case reports in literature [6,7]. Even whenosin staining (A) and immunohistochemical staining of 34βE12 (B),
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disease or bilateral renal metastases [8], but in our patient
the metastasis was single.
As to the treatment, it has to be individualized [9]:
nephrectomy may be considered in the absence of disse-
minated disease or in selected patients with need for palli-
ation. Our patient refused nephrectomy, so we treated her
with Stereotactic Radiosurgery - Gama Knife for the left
kidney. After radiotherapy, the patient remained under
clinical observation.
Conclusions
Renal metastatic tumors from squamous cell lung car-
cinoma are very rare and easy to be neglected, however
we should take into account also the possibility of a me-
tastasis from this tumor when a renal mass is detected.
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